TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14506330

Group type: EXPERIMENTAL
Intervention: Rebamipide (100 mg, 3 times/day for 7 days before surgery)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (group 1 - distal gastrectomy with D2 lymph node dissection)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (group 3 - laparoscopy-assisted distal gastrectomy with D1 lymph node dissection)
Number of subjects: 30
Study: 12748215

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Metoprolol CR/XL
Number of subjects: 10
Study: 9607389

Group type: EXPERIMENTAL
Intervention: Fosinopril (10 to 20 mg daily orally)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Atenolol (25 to 50 mg daily orally)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study: 7614147

Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 64

Group type: COMPARATOR
Intervention: Glass ionomer cement
Number of subjects: 64
Study: 2650581

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg daily
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Quinapril 40 mg daily
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Quinapril 80 mg daily
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: Quinapril (once daily)
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 842526

Group type: EXPERIMENTAL
Intervention: Fasting for 9.1 hours (women)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting for 16.5 hours (women)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting for 16 hours (both sexes)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting for 9 hours (men)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting for 9 hours (women)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting duration (both sexes)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fasting (both sexes)
Number of subjects: 41
Study: 31266460

Group type: EXPERIMENTAL
Intervention: Online genetic education with pre- and post-test telephone genetic counseling
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Online genetic education with optional telephone counseling
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Online genetic education with required pre-test telephone genetic counseling
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Online genetic education with required post-test telephone genetic counseling
Number of subjects: 3000
Study: 28396108

Group type: EXPERIMENTAL
Intervention: Augmented nurse care management intervention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Usual late-stage CKD care
Number of subjects: 130
Study: 25500919

Group type: EXPERIMENTAL
Intervention: Father‐Infant Interaction Program (FIIP) - a video‐modeled play intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Comparison group (control)
Number of subjects: 85
Study: 22809664

Group type: EXPERIMENTAL
Intervention: Paracetamol (60/80/100 mg based on birth weight)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 21336727

Group type: EXPERIMENTAL
Intervention: VitalStim therapy plus conventional swallowing training
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional swallowing therapy
Number of subjects: 120

Group type: COMPARATOR
Intervention: VitalStim therapy
Number of subjects: 120
Study: 19539116

Group type: EXPERIMENTAL
Intervention: Real cervical manipulation + real amitriptyline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Real cervical manipulation + placebo amitriptyline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sham cervical manipulation + real amitriptyline
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Sham cervical manipulation + placebo amitriptyline
Number of subjects: 19
Study: 16918888

Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg/day)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Famotidine (40 mg/day)
Number of subjects: 100
Study: 15306150

Group type: COMPARATOR
Intervention: Normal blood donors (ND)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Patients with venous thrombosis (VT)
Number of subjects: 600
Study: 10654038

Group type: EXPERIMENTAL
Intervention: OGA L film using Lanex Regular screens (Lanex group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Ultra‐Vision film and screens (Ultra-vision group)
Number of subjects: 200
Study: 9299800

Group type: EXPERIMENTAL
Intervention: Fluoxetine alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combination of fluoxetine and cognitive behavior therapy
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control (placebo or waiting list)
Number of subjects: 76
Study: 8345004

Group type: EXPERIMENTAL
Intervention: Sodium valproate 3000 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sodium valproate 2000 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Sodium valproate 1000 mg
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Total drug concentration above 100 mg/l
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Total plasma clearance (Cl)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Intrinsic plasma clearance (Clu)
Number of subjects: 9
Study: 29092079

Group type: EXPERIMENTAL
Intervention: Intranasal benzhydrocodone API (13.34 mg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Intranasal hydrocodone bitartrate API (15.0 mg)
Number of subjects: 51
Study: 26365330

Group type: EXPERIMENTAL
Intervention: 15‐mg zinc sulfate daily from the 16th week of gestation until delivery
Number of subjects: 540

Group type: COMPARATOR
Intervention: No zinc supplementation (control group)
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: 15‐mg zinc sulfate
Number of subjects: 540
Study: 24210923

Group type: EXPERIMENTAL
Intervention: Gastrostomy tube (G-tube) feeding
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Nasogastric tube (N-tube) feeding
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Oral only feeding
Number of subjects: 432
Study: 22658359

Group type: EXPERIMENTAL
Intervention: Itraconazole in addition to DMARD therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard DMARD therapy plus placebo
Number of subjects: 0
Study: 20551499

Group type: EXPERIMENTAL
Intervention: GPAQ
Number of subjects: 251

Group type: COMPARATOR
Intervention: IPAQ
Number of subjects: 251
Study: 18681789

Group type: COMPARATOR
Intervention: 50 mg clomiphene citrate plus placebo (n = 209)
Number of subjects: 626

Group type: COMPARATOR
Intervention: 2 g extended-release metformin plus placebo (n = 208)
Number of subjects: 626

Group type: COMPARATOR
Intervention: Combination of metformin and clomiphene (n = 209)
Number of subjects: 626

Group type: EXPERIMENTAL
Intervention: Metformin XR (2 g/day)
Number of subjects: 626
Study: 16402651

Group type: EXPERIMENTAL
Intervention: Septoplasty alone
Number of subjects: 26

Group type: COMPARATOR
Intervention: Septoplasty plus endoscopic sinus surgery
Number of subjects: 26
Study: 14640057

Group type: EXPERIMENTAL
Intervention: Selective COX-2 inhibitors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-steroidal anti-inflammatory drugs (NSAIDs)
Number of subjects: 0
Study: 10397521

Group type: EXPERIMENTAL
Intervention: 2% minocycline ointment
Number of subjects: 104

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 104
Study: 8934149

Group type: EXPERIMENTAL
Intervention: 4 mg nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0 mg nicotine gum)
Number of subjects: 0
Study: 1676411

Group type: EXPERIMENTAL
Intervention: Safflower oil emulsion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50:50 mixture of safflower and soybean oils
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soybean oil emulsion
Number of subjects: 0
Study: 6364951

Group type: EXPERIMENTAL
Intervention: Intravenous indomethacin
Number of subjects: 169

Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 169

Group type: COMPARATOR
Intervention: Metamizol
Number of subjects: 169
Study: 31310297

Group type: EXPERIMENTAL
Intervention: Flexible visitation (up to 12 hours per day)
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Restricted visitation (median, 1.5 hours per day)
Number of subjects: 1685

Group type: EXPERIMENTAL
Intervention: Flexible visitation
Number of subjects: 1685

Group type: COMPARATOR
Intervention: Restricted visitation
Number of subjects: 1685
Study: 29909019

Group type: EXPERIMENTAL
Intervention: Ustekinumab (130 mg or 6 mg/kg intravenous)
Number of subjects: 334

Group type: EXPERIMENTAL
Intervention: Ustekinumab (subcutaneous 90 mg every 12 weeks or 8 weeks)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 26831676

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PDT
Number of subjects: 118

Group type: COMPARATOR
Intervention: Bronchoscopy-guided PDT
Number of subjects: 118
Study: 25275724

Group type: EXPERIMENTAL
Intervention: MVA E2 therapeutic vaccine (10^7 virus particles injected directly into uterus, urethra, vulva, or anus)
Number of subjects: 1356
Study: 22797511

Group type: EXPERIMENTAL
Intervention: Summer
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Autumn
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Winter
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Spring
Number of subjects: 85
Study: 19363022

Group type: EXPERIMENTAL
Intervention: Dexamethasone (100 mg intramuscular injections at baseline and 6 weeks)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 16378563

Group type: EXPERIMENTAL
Intervention: Nurse Practitioner Consultations
Number of subjects: 36
Study: 11927515

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEEs) 0.625 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Combination of CEEs and simvastatin
Number of subjects: 28
Study: 10319000

Group type: EXPERIMENTAL
Intervention: Virtual endoscopy (VE)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Bronchoscopy
Number of subjects: 21
Study: 7500130

Group type: EXPERIMENTAL
Intervention: Daily 2‐h manual practice sessions for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group 1: Daily TMS mapping without piano practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group 2: Played the piano at will for 2 h each day using only the right hand without specific skill learning
Number of subjects: 0
Study: 2613427

Group type: COMPARATOR
Intervention: Very low calorie diet alone
Number of subjects: 76

Group type: COMPARATOR
Intervention: Behavior therapy alone
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Combined treatment (very low calorie diet + behavior therapy)
Number of subjects: 76
Study: 773495

Group type: EXPERIMENTAL
Intervention: Dipyridamole and aspirin (given by mouth from the evening before operation and for seven days after operation)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no treatment specified)
Number of subjects: 160
Study: 31842127

Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid treatment
Number of subjects: 497

Group type: COMPARATOR
Intervention: Non-acetylsalicylic acid treatment
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Post-operative bleeding
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Patient satisfaction
Number of subjects: 497
Study: 30355861

Group type: EXPERIMENTAL
Intervention: SMILE
Number of subjects: 215

Group type: COMPARATOR
Intervention: FS-LASIK
Number of subjects: 215
Study: 26769332

Group type: EXPERIMENTAL
Intervention: INCB039110 100 mg once daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: INCB039110 200 mg once daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: INCB039110 200 mg twice daily
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: INCB039110 600 mg once daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 25171502

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.4 mg (TAM) + Solifenacin 5 mg (SOL)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg (TAM)
Number of subjects: 280
Study: 22617536

Group type: EXPERIMENTAL
Intervention: En bloc resection for HCC extending to adjacent organs
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (HCC without adjacent organ extension)
Number of subjects: 168
Study: 20509073

Group type: EXPERIMENTAL
Intervention: Hypnotherapy with personal imagery preferences for coolness
Number of subjects: 51
Study: 17618427

Group type: EXPERIMENTAL
Intervention: Tolfenamic acid 200 mg t.i.d. for 3 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15908834

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS) at doses of 0.45 mg/h, 0.9 mg/h, and 1.8 mg/h
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Methylphenidate transdermal system (MTS)
Number of subjects: 36
Study: 11842306

Group type: EXPERIMENTAL
Intervention: Children from eastern Germany
Number of subjects: 12501

Group type: COMPARATOR
Intervention: Children from western Germany
Number of subjects: 12501
Study: 10469092

Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated caffeine-based cream (higher concentration)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Liposome-encapsulated caffeine-based cream (lower concentration)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 41
Study: 7605021

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 545

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 545
Study: 2153719

Group type: EXPERIMENTAL
Intervention: Topical nedocromil sodium
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 7018644

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 0.5 mg/kg (n = 43)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Promethazine 0.5 mg/kg (n = 40)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Diazepam 0.1 mg/kg (n = 378)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo (n = 36)
Number of subjects: 159
Study: 31898489

Group type: EXPERIMENTAL
Intervention: Continuous Storage Root Formation and Bulking (CSRFAB)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Discontinuous Storage Root Formation and Bulking (DSRFAB)
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: CSRFAB genotypes
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Growth patterns of sweetpotato genotypes
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Broad sense heritability of CSRFAB
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Reproducibility of measurements
Number of subjects: 130
Study: 31727664

Group type: EXPERIMENTAL
Intervention: Rotarix (third dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 0
Study: 28006991

Group type: EXPERIMENTAL
Intervention: ABM-MSCs
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: ABM-MNCs
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (sham procedure)
Number of subjects: 30
Study: 25601979

Group type: EXPERIMENTAL
Intervention: Adenotonsillectomy
Number of subjects: 453

Group type: COMPARATOR
Intervention: Watchful waiting
Number of subjects: 453
Study: 22429586

Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week (eow) as continuous treatment
Number of subjects: 460

Group type: COMPARATOR
Intervention: Adalimumab 40 mg every other week (eow) after retreatment
Number of subjects: 460

Group type: COMPARATOR
Intervention: Retreatment with adalimumab
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Adalimumab continuous treatment
Number of subjects: 460
Study: 22016976

Group type: EXPERIMENTAL
Intervention: Method for calming the liver and suppressing Yang (Traditional Chinese Medicine)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Thiamazole tablets
Number of subjects: 48
Study: 19845951

Group type: EXPERIMENTAL
Intervention: Single-day cord cleansing with 4.0% chlorhexidine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 7-day cord cleansing with 4.0% chlorhexidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Promotion of dry cord care as recommended by WHO
Number of subjects: 0
Study: 16903243

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE) 0.625mg/day orally for 3 months
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 15560702

Group type: EXPERIMENTAL
Intervention: Head balance exercise (Group 2)
Number of subjects: 1565

Group type: COMPARATOR
Intervention: No head balance exercise (Group 1)
Number of subjects: 1565
Study: 10690131

Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV) at 60, 100, 150, and 200 bpm (HFJV.p and HFJV.d)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Valveless high frequency jet ventilator (VPP)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High frequency jet ventilation (HFJV)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lung model with variable compliance and resistance
Number of subjects: 12
Study: 9177609

Group type: EXPERIMENTAL
Intervention: UVB treatment (15 patients)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: PUVA treatment (11 patients)
Number of subjects: 26
Study: 1683578

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cefuroxime plus metronidazole
Number of subjects: 85
Study: 6123339

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ORG NC 45
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pancuronium
Number of subjects: 0
Study: 30249435

Group type: EXPERIMENTAL
Intervention: Hospital clown-nurse during burn dressing change
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care without hospital clown (Control)
Number of subjects: 50
Study: 27687613

Group type: EXPERIMENTAL
Intervention: BMI increase
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Triglycerides increase
Number of subjects: 787

Group type: EXPERIMENTAL
Intervention: Fasting glucose levels
Number of subjects: 787
Study: 24354930

Group type: EXPERIMENTAL
Intervention: ePULab e-learning tool
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional on-campus class
Number of subjects: 100
Study: 22722512

Group type: EXPERIMENTAL
Intervention: MK-0657 monotherapy (4-8 mg/d)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 20102832

Group type: EXPERIMENTAL
Intervention: Cover flow (collages of foods in a category)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Tree view (food categories in a list)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Child-generated food categories
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Professionally generated food categories
Number of subjects: 104
Study: 17659076

Group type: EXPERIMENTAL
Intervention: Computer based sessions
Number of subjects: 55

Group type: COMPARATOR
Intervention: Lecture based sessions
Number of subjects: 55
Study: 16162046

Group type: EXPERIMENTAL
Intervention: Perceived social consensus feedback indicating more favorable attitudes toward obese people (Study 1)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Perceived social consensus feedback from an in-group source (Study 2)
Number of subjects: 315

Group type: COMPARATOR
Intervention: Consensus approach compared with other stigma reduction methods (Study 3)
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Information about uncontrollable causes of obesity and supposed scientific prevalence of traits (Study 3)
Number of subjects: 315
Study: 12113286

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg per day
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 10892417

Group type: COMPARATOR
Intervention: Beta-agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxytocin antagonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nitric oxide donors
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various approaches for secondary prevention
Number of subjects: 0
Study: 8750221

Group type: EXPERIMENTAL
Intervention: Intraperitoneal (IP) insulin infusion at 2 mU/kg‐1 min‐1
Number of subjects: 12

Group type: COMPARATOR
Intervention: Intravenous (IV) insulin infusion at 1 mU/kg‐1 min‐1
Number of subjects: 12
Study: 2025692

Group type: EXPERIMENTAL
Intervention: Abstinence
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Controlled gambling
Number of subjects: 63

Group type: COMPARATOR
Intervention: Uncontrolled gambling
Number of subjects: 63
Study: 6358126

Group type: EXPERIMENTAL
Intervention: High dose nimodipine therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nifedipine and verapamil
Number of subjects: 35
Study: 30855740

Group type: EXPERIMENTAL
Intervention: Flexible duty-hour rules (no specified limits on shift length or mandatory time off)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard duty hours (as per ACGME guidelines)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Flexible duty-hour rules
Number of subjects: 63

Group type: COMPARATOR
Intervention: Standard duty hours
Number of subjects: 63
Study: 29914785

Group type: EXPERIMENTAL
Intervention: 0.1% bupivacaine
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Lower concentration groups (0.0625%, 0.1%)
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Higher concentrations
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Satisfaction score 72 hours after delivery
Number of subjects: 237
Study: 27477254

Group type: EXPERIMENTAL
Intervention: Focused ESWT plus Isokinetic Exercise (IE)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Focused ESWT
Number of subjects: 30
Study: 27128606

Group type: EXPERIMENTAL
Intervention: Single dose (SD) of GSK2018682 up to 24 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeat dose (RD) of GSK2018682 up to 6 mg/day for 28 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK2018682
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK2018682 in fed state
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK2018682 RD of 6 mg
Number of subjects: 0
Study: 22381223

Group type: EXPERIMENTAL
Intervention: Alcohol-based antiseptic containing chlorhexidine gluconate (CHG)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alcohol-only antiseptics
Number of subjects: 0